Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine

X Wang, P Hua, C He, M Chen - Acta Pharmaceutica Sinica B, 2022 - Elsevier
As an emerging cancer therapeutic target, non-apoptotic cell death such as ferroptosis,
necroptosis and pyroptosis, etc., has revealed significant potential in cancer treatment for …

Nanovehicles for co-delivery of anticancer agents

M Zeinali, S Abbaspour-Ravasjani, M Ghorbani… - Drug discovery today, 2020 - Elsevier
Highlights•Discusses biological advantages of co-delivery of multiple agents in cancer
therapy.•Nanovehicles can be used for simultaneous delivery of drug–drug or drug–gene …

Nanomedicine in treatment of breast cancer–A challenge to conventional therapy

M Afzal, KS Alharbi, NK Alruwaili, FA Al-Abassi… - Seminars in cancer …, 2021 - Elsevier
Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and
known as the leading cause of death among women globally. The extensive interdisciplinary …

[HTML][HTML] Autophagy in cancer resistance to paclitaxel: Development of combination strategies

J Škubník, VS Pavlíčková, T Ruml… - Biomedicine & …, 2023 - Elsevier
Paclitaxel, a compound naturally occurring in yew, is a commonly used drug for the
treatment of different types of cancer. Unfortunately, frequent cancer cell resistance …

Cardioprotective role of melatonin in acute myocardial infarction

Z Fu, Y Jiao, J Wang, Y Zhang, M Shen… - Frontiers in …, 2020 - frontiersin.org
Melatonin is a pleiotropic, indole secreted, and synthesized by the human pineal gland.
Melatonin has biological effects including anti-apoptosis, protecting mitochondria, anti …

[HTML][HTML] Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast …

YM Chen, W Xu, Y Liu, JH Zhang, YY Yang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Anomanolide C (AC), a natural withanolide isolated from Tubocapsicum anomalum, has
been reported to have exhibits remarkable anti-tumour activities in several types of human …

[HTML][HTML] Design, synthesis, and biological evaluation of quinazolin-4 (3H)-one derivatives co-targeting poly (ADP-ribose) polymerase-1 and bromodomain containing …

X Chang, D Sun, D Shi, G Wang, Y Chen… - … Pharmaceutica Sinica B, 2021 - Elsevier
This study was aimed to design the first dual-target small-molecule inhibitor co-targeting
poly (ADP-ribose) polymerase-1 (PARP1) and bromodomain containing protein 4 (BRD4) …

Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy

D Mei, L Gong, Y Zou, D Yang, H Liu, Y Liang… - Journal of Controlled …, 2020 - Elsevier
Chemotherapy post cancer surgery has important clinical significance for reducing the
chance of recurrent-metastasis. However, postoperative chemotherapy efficacy is hampered …

ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells

DF Xue, ST Pan, G Huang, JX Qiu - … journal of biochemistry & cell biology, 2020 - Elsevier
Cisplatin is one of the most widely used anticancer agents for patients with tongue
squamous cell carcinoma (TSCC), but its efficacy is limited by chemoresistance …

[HTML][HTML] Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms

P Famta, S Shah, E Chatterjee, H Singh, B Dey… - Current Research in …, 2021 - Elsevier
Abstract The high probability (13%) of women developing breast cancer in their lifetimes in
America is exacerbated by the emergence of multidrug resistance after exposure to first-line …